Ranking of Administrative Districts of Almaty City by Incidence of Hepatitis B and C

Lyazat Zh. Orakbay, PhD, ScD*; Maria N. Omarova, PhD, ScD; Idelbay Kh. Shuratov, PhD,ScD; Aizhan B. Dzhumagalieva, PhD

Scientific Centre of Hygiene and Epidemiology named after Hamza Zhumatov; Almaty, Kazakhstan

*Corresponding author: Lyazat Orakbay, PhD, ScD. Scientific Centre of Hygiene and Epidemiology named after Hamza Zhumatov. Almaty, Kazakhstan. E-mail: ncgigieny@mail.ru

Published: September 16, 2017.  doi: 10.21103/Article7(3)_OA16


The incidence of acute and chronic hepatitis B and C in the districts of Almaty city over the past 10 years is presented in this article.

acute hepatitis B ● acute hepatitis C ● chronic hepatitis B ● chronic hepatitis C ● vaccination

1. WHO. Hepatitis B. Available from: http://www.who.int/mediacentre/factsheets/fs204/en/ Accessed June 22, 2014.
2. "Hepatitis B vaccines: WHO position paper", October 2009. WER. Available from: http://www.who.int/wer/2009/wer8440/en/
3. Sulkowski MS1, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002 Jul 10;288(2):199-206.
4. Ciesek S, Friesland M, Steinmann J, Becker B, Wedemeyer H, Manns MP, Steinmann J, Pietschmann T, Steinmann E. How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides. J Infect Dis. 2010 Jun 15;201(12):1859-66. doi: 10.1086/652803.
5. Paintsil E1, He H, Peters C, Lindenbach BD, Heimer R. Survival of hepatitis C virus in syringes: implication for transmission among injection drug usersJ Infect Dis. 2010 Oct 1;202(7):984-90. doi: 10.1086/656212.
6. WHO. Hepatitis C Fact sheet Updated July 2017. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/
7. Surveillance for Viral Hepatitis – United States, 2014. Available from:https://www.cdc.gov/hepatitis/statistics/2014surveillance/index.htm
8. Utegenova ES, Shuratov IKh, Khan OE. Hepatitis C morbidity in Kazakhstan. Gigiena Epidemiologia I Immunologia. 2008; (3):66-70.[Article in Russian].
9. Sergey Mukomolov,† Galina Trifonova, Irina Levakova, Daria Bolsun, and Eugenia Krivanogova.Hepatitis C in the Russian Federation: challenges and future directions. Hepat Med. 2016; 8: 51–60. Published online 2016 May 5. doi: 10.2147/HMER.S50172
10. Vitalina V. Klushkina, Karen K. Kyuregyan, Tatiana V. Kozhanova, Oksana E. Popova, Polina G. Dubrovina, Olga V. Isaeva, Ilya V. Gordeychuk, Mikhail I. Mikhailov. Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia. PLoS One. 2016; 11(6): e0157161.Published online 2016 Jun 9. doi: 10.1371/journal.pone.0157161
11. Quinti I, Hassan NF, El Salman D, Shalaby H, El Zimatty D, Monier MK, Arthur RR. Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C. J Hepatol. 1995; 23:640–7.
12. Pawlotsky JM. Molecular diagnosis of viral hepatitis. Gastroenterology. 2002;122(6):1554-68.

The fully formatted PDF version is available.
Download Article
International Journal of Biomedicine. 2017;7(3):240-242. ©2017 International Medical Research and Development Corporation. All rights reserved.